4th Quarter - Report — ADVANCED POLICY CONSULTING, LLC for AMGEN USA INC. (2017)

Firm

ADVANCED POLICY CONSULTING, LLC

Client

AMGEN USA INC.

Income

$50,000

Expenses

—

What was lobbied

2 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

Market based solutions to bring down the cost of drug prices. Centers for Medicare & Medicaid Services (CMS) new coding regulation on biosimilar drug products. Issuing new codes in a timely fashion for the Medicare End-Stage Renal Disease (ESRD) Program.

Lobbyist	Covered position, as disclosed
MATTHEW MCGINLEY	—

Contacted: Treasury, Dept of; Food & Drug Administration (FDA); HOUSE OF REPRESENTATIVES; Centers For Medicare and Medicaid Services (CMS); SENATE; Natl Economic Council (NEC); Health & Human Services, Dept of (HHS)

Taxation/Internal Revenue Code TAX

Tax Reform: International tax provisions as it relates to the taxation of income derived from intangible property. Tax Reform: International tax provisions as it relates to U.S. companies who do business in Puerto Rico.

Lobbyist	Covered position, as disclosed
MATTHEW MCGINLEY	—

Contacted: Food & Drug Administration (FDA); Treasury, Dept of; HOUSE OF REPRESENTATIVES; Natl Economic Council (NEC); Centers For Medicare and Medicaid Services (CMS); SENATE; Health & Human Services, Dept of (HHS)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.